Weight-Loss Injections or Bariatric Surgery? A Clear Comparison

They are weekly injections that mimic natural gut hormones, reducing appetite and slowing how fast the stomach empties. The effect lasts as long as the medicine is taken.

In the SURMOUNT-1 trial, people lost 15% to 20.9% of body weight at 72 weeks depending on the tirzepatide dose, and 4% to 7% stopped because of side effects. In the STEP 1 extension, participants lost about 17% with semaglutide, then regained two-thirds of it within a year of stopping.

Less common but more serious risks include pancreatitis and gallstones. These medicines are not used in pregnancy, or with a personal or family history of medullary thyroid cancer (MTC) or MEN2 syndrome.

• Moderate excess weight, or a BMI below the level where surgery is recommended.
• You are not ready for surgery, or have a medical reason to avoid it.
• You are prepared to stay on the medicine long-term and cover its ongoing cost.

The international societies ASMBS and IFSO recommend metabolic and bariatric surgery for a BMI of 35 or more, and consider it from 30 to 34.9 with metabolic disease such as diabetes. They describe it as a highly effective, evidence-based treatment for obesity across all BMI classes. Details are in Who qualifies for sleeve gastrectomy and Bariatric surgery in Dubai.

Yes, in selected cases: before surgery to bring weight down in patients with very high BMI, or after surgery if weight starts to return. Your doctor decides this case by case (see Weight regain after sleeve).

See a doctor urgently if you develop severe, persistent abdominal pain that may spread to the back, or vomiting that stops you keeping fluids down while on injections. Do not start or stop weight-loss injections without a medical assessment.